BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36705024)

  • 1. The road to pandemic recovery: Tracking COVID-19's impact on cirrhosis care and outcomes among 111,558 Veterans.
    Adejumo AC; Yakovchenko V; Morgan TR; Spoutz P; Chia L; Bajaj JS; Chang MF; Dominitz JA; Rogal SS
    Hepatology; 2023 Jun; 77(6):2016-2029. PubMed ID: 36705024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The COVID-19 Pandemic Highlights Opportunities to Improve Hepatocellular Carcinoma Screening and Diagnosis in a National Health System.
    Kim NJ; Rozenberg-Ben-Dror K; Jacob DA; Berry K; Ioannou GN
    Am J Gastroenterol; 2022 Apr; 117(4):678-684. PubMed ID: 35029156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Care Utilization and Hepatocellular Carcinoma Surveillance: Tracking Care Across the Pandemic.
    Serper M; Tapper EB; Kaplan DE; Taddei TH; Mahmud N
    Am J Gastroenterol; 2023 Feb; 118(2):294-303. PubMed ID: 36114778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of patients with cirrhosis presenting with bleeding gastric varices.
    Nakazawa M; Imai Y; Sugawara K; Uchida Y; Saitoh Y; Fujii Y; Uchiya H; Ando S; Nakayama N; Tomiya T; Mochida S
    PLoS One; 2022; 17(3):e0264359. PubMed ID: 35290384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MELD-Lactate Predicts Poor Outcome in Variceal Bleeding in Cirrhosis.
    Horvatits T; Mahmud N; Serper M; Seiz O; Reher D; Drolz A; Sarnast N; Gu W; Erasmus HP; Allo G; Ferstl P; Wittmann S; Piecha F; Groth S; Zeuzem S; Schramm C; Huber S; Rösch T; Lohse AW; Trebicka J; Ogola G; Asrani SK; Kluwe J
    Dig Dis Sci; 2023 Mar; 68(3):1042-1050. PubMed ID: 36376577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma.
    Kim JH; Sinn DH; Kim K; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Dig Dis Sci; 2016 Nov; 61(11):3354-3362. PubMed ID: 27435325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Outcomes and Prognostic Factors of Acute Variceal Bleeding in Patients with Hepatocellular Carcinoma.
    Lee YR; Park SY; Tak WY
    Gut Liver; 2020 Jul; 14(4):500-508. PubMed ID: 31816673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis.
    Huang DQ; Tan DJH; Ng CH; Amangurbanova M; Sutter N; Lin Tay PW; Lim WH; Yong JN; Tang A; Syn N; Muthiah MD; Tan EXX; Dave S; Tay B; Majzoub AM; Gerberi D; Kim BK; Loomba R
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1169-1177. PubMed ID: 35940513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular Carcinoma Diagnosis and Management in 2021: A National Veterans Affairs Quality Improvement Project.
    Rogal SS; Taddei TH; Monto A; Yakovchenko V; Patton H; Merante M; Spoutz P; Chia L; Yudkevich J; Aytaman A; Rabiee A; John BV; Blechacz B; Cai CX; Gilles H; Shah AS; McCurdy H; Puri P; Jou J; Mazhar K; Dominitz JA; Anwar J; Morgan TR; Ioannou GN
    Clin Gastroenterol Hepatol; 2024 Feb; 22(2):324-338. PubMed ID: 37460005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of an algorithm using inpatient electronic health records to determine the presence and severity of cirrhosis in patients with hepatocellular carcinoma in England: an observational study.
    Driver RJ; Balachandrakumar V; Burton A; Shearer J; Downing A; Cross T; Morris E; Rowe IA
    BMJ Open; 2019 Jul; 9(7):e028571. PubMed ID: 31292182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems.
    Sclair SN; Carrasquillo O; Czul F; Trivella JP; Li H; Jeffers L; Martin P
    Dig Dis Sci; 2016 Oct; 61(10):2857-2867. PubMed ID: 27289585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis.
    Navadurong H; Thanapirom K; Wejnaruemarn S; Prasoppokakorn T; Chaiteerakij R; Komolmit P; Treeprasertsuk S
    World J Gastroenterol; 2023 Aug; 29(32):4873-4882. PubMed ID: 37701131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should we continue surveillance for hepatocellular carcinoma and gastroesophageal varices in patients with cirrhosis and cured HCV infection?
    Isfordink CJ; Maan R; de Man RA; van Erpecum KJ; van der Meer AJ
    Eur J Intern Med; 2021 Dec; 94():6-14. PubMed ID: 34563447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients.
    Lin PT; Teng W; Jeng WJ; Hsieh YC; Hung CF; Huang CH; Lui KW; Chen YC; Lin CC; Lin SM; Sheen IS; Lin CY
    J Formos Med Assoc; 2020 Feb; 119(2):635-643. PubMed ID: 31495543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognosis Analysis of Liver Cirrhosis with Acute Variceal Bleeding and Validation of Current Prognostic Models: A Large Scale Retrospective Cohort Study.
    Zhao Y; Ren M; Lu G; Lu X; Yin Y; Zhang D; Wang X; Ma W; Li Y; Cai G; Lin Y; He S
    Biomed Res Int; 2020; 2020():7372868. PubMed ID: 32879889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States.
    Kaplan DE; Chapko MK; Mehta R; Dai F; Skanderson M; Aytaman A; Baytarian M; D'Addeo K; Fox R; Hunt K; Pocha C; Valderrama A; Taddei TH;
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):106-114.e5. PubMed ID: 28756056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma predicts in-hospital mortality from acute variceal hemorrhage among patients with cirrhosis.
    Singal AK; Jampana SC; Singal V; Kuo YF
    J Clin Gastroenterol; 2012 Aug; 46(7):613-9. PubMed ID: 22772741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
    Goldberg DS; Taddei TH; Serper M; Mehta R; Dieperink E; Aytaman A; Baytarian M; Fox R; Hunt K; Pedrosa M; Pocha C; Valderrama A; Kaplan DE
    Hepatology; 2017 Mar; 65(3):864-874. PubMed ID: 27531119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telephone-Only Visits Preserved Hepatocellular Cancer Screening Rates in Patients with Cirrhosis Early in the COVID-19 Pandemic.
    Rudnick SR; Ugwuegbu J; Soufleris SJ; Bundy R; Dharod A; Russo MW
    Dig Dis Sci; 2023 May; 68(5):1791-1796. PubMed ID: 36562886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.